UK Biobank SARS-CoV-2 Serology Study
- Funded by UK Research and Innovation (UKRI)
- Total publications:0 publications
Grant number: C19-IUC-227
Grant search
Key facts
Disease
COVID-19Funder
UK Research and Innovation (UKRI)Principal Investigator
Rory CollinsResearch Location
United KingdomLead Research Institution
UK BiobankResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Immunity
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Not applicable
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
Thousands of UK Biobank participants are being asked to take part in a major government study to measure the extent of coronavirus infection in different regions across the UK. Those who agree to take part will provide monthly blood samples for at least six months so that their levels of immunity (antibodies in their blood) can be measured. Researchers will use the information to determine the extent of the infection in different regions across the UK and to understand how long antibody levels persist following infection. This major study will complement existing studies, such as the ONS Covid-19 Infection Survey, which through nasal swabs is testing for presence of the virus and will collect blood samples from 1,000 adults in English households. By collecting blood samples from 20,000 participants across the UK to understand immunity to Covid-19, UK Biobank will contribute to national efforts to ease lock-down measures.